Health is on our radar.
We make the XK300, the sensor that measures heart rate and breathing through the air, from the wall, all night, with nothing worn. FDA-cleared since 2021. On hospital wards, in nursing homes, in homes and in correctional facilities, and now in a consumer product of its own.
One sensor. Numbers you can check.
One radar. Two ways to reach people.

The XK300 family, prescribed and installed.
Hospitals, long-term care, home health and remote patient monitoring, correctional and behavioural health. The XK300 on the wall or ceiling, the XK300 Essence for the home, and the platform their teams read.

Kardian, the same radar science for your own home.
Kardian Somily is a separate general wellness product built on our radar technology, sold to individuals. It is not the cleared medical device, and it never asks you to wear anything.
The same impulse-radio radar also confirms presence and counts people in buildings. Those sensors are sold through partners; ask us through the partnerships route.
A pulse goes out. The chest answers.
The XK300 sends an ultra-wideband radar pulse at a very low power, in the same frequency range as Wi-Fi, and reads the movement of the chest as it comes back: the rise of breathing, and under it, the beat of the heart. Through a duvet. Through a mattress. Nothing on the person.
Every reading is compared with the person's own recent nights, not a textbook range. That is the idea the company was built on, and the reason care teams notice change early.
The science, in full ↗
Every room where someone is in another's care.





Deployed in the United States, Canada, Australia, the United Kingdom and Ireland, Hong Kong, Singapore, Korea, Japan and the Gulf, directly and through partners.
The latest.



Toronto
Seoul
On siteRadar scientists, clinicians and operators.
A core of PhD radar engineers in Seoul, a clinical and customer team across North America, and a board that has built and sold medical and technology companies before.
